Brackmann Christoph bought NVCR
March 4, 2025 · Form 4 insider transaction
Brackmann Christoph bought 81,499 shares of NovoCure Limited at $18.19 per share, a transaction worth $1.48M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
81,499
Price
$18.19
Total value
$1.48M
InsiderBrackmann Christoph
RoleOfficer
CompanyNovoCure Limited (NVCR)
SecurityStock Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 4, 2025
Filing dateMarch 6, 2025
Shares owned after81,499
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates.